This inventor holds 6 USPTO granted patents and 9 published patent applications. Top assignee: Direct Biologics, LLC. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations of Timothy Alexander Moseley
Introduction
Timothy Alexander Moseley is a notable inventor based in Fallbrook, CA (US). He has made significant contributions to the field of medical treatments, particularly in addressing inflammatory conditions associated with infectious diseases. With a total of 6 patents to his name, Moseley's work is recognized for its innovative approaches and therapeutic applications.
Latest Patents
Moseley's latest patents include groundbreaking methods and compositions for treating inflammatory conditions. One of his patents discloses methods for treating perianal fistula by administering a therapeutic mesenchymal stem cell (MSC) secretome product. This product is made by culturing bone marrow-derived MSCs under specific conditions, including oxygen tension below 5% and a culture media with a pH below 7. Another patent outlines compositions comprising an MSC preparation and various biomolecules, aimed at treating microbial infections and the associated symptoms or secondary pathological conditions.
Career Highlights
Throughout his career, Timothy has focused on developing innovative solutions in the medical field. His work has led to advancements in the treatment of complex inflammatory conditions, showcasing his dedication to improving patient outcomes through scientific research and innovation.
Collaborations
Moseley has collaborated with notable professionals in his field, including Kenneth Allen Pettine and Kevin Hicok. These collaborations have further enhanced the impact of his inventions and contributed to the advancement of medical treatments.
Conclusion
Timothy Alexander Moseley is a distinguished inventor whose work in medical innovations has the potential to transform treatment methodologies for inflammatory conditions. His contributions, particularly in the realm of mesenchymal stem cell therapies, highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile